Reinstating elective hip and knee arthroplasty services presents significant challenges. We need to be honest about the scale of the obstacles ahead and realise that the health challenges and economic consequences of the COVID-19 pandemic are potentially devastating.We must also prepare to make difficult ethical decisions about restarting elective hip and knee arthroplasty. These decisions should be based on the existing evidence-base, reliable data, the recommendations of experts, and regional circumstances.
Keywords: COVID-19; Coronavirus disease 2019; SARS-CoV-2; coronavirus 2; economic; ethical challenge; healthcare; orthopaedic; revision arthroplasty; severe acute respiratory syndrome; total hip arthroplasty; total knee arthroplasty.